LABDX has operates a total telemedicine platform LIFE Platform) to serve the global and local market. Providing two services. Primary Care Network Service ( Local market) providing acomplete telemedicine service available to all 110 M Filipinos. And A Global Service that provides a HealthCare concierge service to not only monitor and navigate the patient, but to provide specific TeleDiagnostics.
• A Digital Health Village providing a scalable primary care network for 100M Filipinos backedby a network of medical specialists.
• LIFE will be the largest Primary Network generating revenues from all healthcare servicesprovided.
• LIFE will provide each patient a nurse to care for them from birth to death.
TELETEST
Pandemic and post pandemic, testing will be required to
monitor and safeguard workers and travelers.
LABx Teletesting services has tested over 2 million patients
remotely providing safe to work and safe to travel certification
from the comfort of the patients home or office. Leveraging
Filipino nurses, LABX has been a competitive provider of
teletesting services.
vpass App
BLOCKCHAIN & AI-POWERED
The system that manages, verifies communicable disease test results and immunization status.
COUNTERFEIT-PROOF | multi-level security features
IMMUNIZATION & TESTING MANAGEMENT | Secure digital records for vaccination and testing
fina home
DRY FLOURESCENCE IMMUNOASSAY (HANDHELD)
Providing remote diagnosis
TEST ITEMS:
COVID-19, DIABETES, INFLAMMATION, CARDIAC, HORMONE,GASTRIC FUNCTION,
TUMOR.
FINA-ER Series
Point of Care Immunochemistry series
FINA – a Point of Care Immunochemistry series directed to
urgent care diagnostics (cardia/inflammatory) – over 50
parameters available..
STD (Sexual Transmitted Disease)
Test Kits
Self-Test Kits
STDs usually comes in pairs. This is 3 of several STD self test kits to be
launched by LABDX
ARIA Test Kits
Qualitative Antigen Rapid Immunoassay and visual read test
ARIA ( antigen rapid immune assay ) Home use/self test that is Affordable, Accurate, accessible & backed by the most advanced digital medical platforms.
A simple Swab – DROP – wait 3 easy steps to test yourself. And, you can scan for a nurse using our teletest service ( MEDX) where an English speaking nurse ( other languages available) virtually & face to face administers the simple steps and provides interpretation of results. This is required for medical certification and in regulated markets.
The Aria is integrated with Symptoma the only Artificial intelligent digital health assistant that has been awarded a Medical device Type authorization. www.symptoma.com
Regulatory approvals include the EU , PH and many other nations.
FINA Ag Test Kits
Quantitative antigen testing for initial diagnosis
FINA Ag is a dry fluorescence immunoassay (FIA) quantitative antigen screen test which can detect the viral presence of SARS-CoV-2 via a painless nasal swab that only takes 15 minutes. It has a sensitivity rating of 100% and a specificity rating of 100%. FINA Ag is our most affordable SARS-CoV-2 viral test by far, and it is known to be highly accurate, accessible (available at point-of-care), and affordable. Call us for special introductory pricing.
COVID-19 RISK PANEL (CRP)
COVID19 RISK PANEL (CRP) includes measurement of seven (7) parameters namely – Glycosylated Hemoglobin (HBA1C), Vitamin D, C-Reactive Protein, Procalcitonin, Interleukin-6, D-Dimer, & Troponin I. These parameters gives information on an individual’s immune status and predisposition to moderate to critical COVID19 complications.
NAbs (Neutralizing Antibodies)
nAbs (Neutralizing Antibodies) is a quantitative gold standard in measuring vaccine efficacy and immunity.
CAI-1
Qualitative antigen testing without the need for machines
Qualitative antigen testing without the need for machines with a sensitivity of 94.7% Sensitivity and specificity of 97.7%, the Corona Antigen Instant Test for 1 (or CAI-1) contains two antigen tests that can be detected without the use of machines, making it suitable for at-home use with the aid of a licensed medical practitioner.
AgILA
Quantitative antigen fluorescence immunoassay test
Rated at 96% sensitivity and 99% specificity, the AgILA uses a machine to detect the presence of COVID-19 antigens or proteins in subjects. Exclusive to select government agencies at the moment.
